The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to ...

Cellular therapies that harness a patient’s own immune system to identify and eliminate cancer cells are rapidly expanding ...

Millions of Americans take daily supplements-nicotinamide mononucleotide (NMN), nicotinamide riboside (NR) and nicotinamide ...

Researchers from The University of Texas MD Anderson Cancer Center have developed a first-in-class antibody that targets a ...

High-dose vitamin B3 (niacin) may boost immune function and slow glioblastoma progression, with 82% of trial patients showing ...

UCLA researchers developed a human stem cell-derived cell therapy for an aggressive type of breast cancer. This study focused ...

Scientists have developed a method to reprogram cancer-fighting immune cells directly inside the body, potentially ...

The post HYD Pioneers New Research Revealing Systemic Role of Deuterium-Depleted Water in Cancer Therapy appeared first on ...

A new CAR T-cell therapy attacks supportive cells in the tumor microenvironment that bear the surface protein, uPAR.

A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers ...

How can cancer cells be targeted without damaging healthy tissue? This is one of the major challenges facing oncology today.

A 26-year-old is now "cancer-free" after receiving a new treatment for colorectal cancer. "I was declared cancer free in July ...